Immobilization-Induced Hypercalcemia in COVID-19 With a Prolonged Intensive Care Unit Stay

被引:4
作者
Kannan, Lakshmi [1 ]
Raj, Rishi [2 ]
Rhoad, William [3 ]
Akella, Ramya [4 ]
Jacob, Aasems [5 ]
机构
[1] Pikeville Med Ctr, Nephrol, Pikeville, KY 41501 USA
[2] Pikeville Med Ctr, Endocrinol, Pikeville, KY USA
[3] Univ Pikeville Kentucky, Coll Osteopath Med, Internal Med, Pikeville, KY USA
[4] Pikeville Med Ctr, Internal Med, Pikeville, KY USA
[5] Pikeville Med Ctr, Hematol & Oncol, Pikeville, KY USA
关键词
renal replacement therapy; immobilization; physical therapy; bisphosphonates; covid-19; hypercalcemia;
D O I
10.7759/cureus.24081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immobilization is an uncommon etiology of hypercalcemia. It is usually seen in conditions associated with limited movements such as spinal cord injuries, vascular events, or following prolonged hospitalization. Hereby, we present a case of a young patient who had prolonged hospitalization following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). During her prolonged and complicated hospital stay, she developed severe hypercalcemia secondary to immobilization, which was resistant to treatment with hydration, calcitonin, and denosumab. One dose of zoledronic acid was used, although the patient was on hemodialysis, with adequate response in calcium levels. This case illustrates that patients with COVID-19-related hospitalization are at increased risk of immobilization-induced hypercalcemia, likely due to prolonged hospital stay due to critical illness and lack of early physical therapy during hospitalization.
引用
收藏
页数:4
相关论文
共 13 条
[1]   The response of bone to unloading [J].
Bikle, DD ;
Halloran, BP .
JOURNAL OF BONE AND MINERAL METABOLISM, 1999, 17 (04) :233-244
[2]  
Carroll MF, 2003, AM FAM PHYSICIAN, V67, P1959
[3]   Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19 [J].
Di Filippo, Luigi ;
Formenti, Anna Maria ;
Rovere-Querini, Patrizia ;
Carlucci, Michele ;
Conte, Caterina ;
Ciceri, Fabio ;
Zangrillo, Alberto ;
Giustina, Andrea .
ENDOCRINE, 2020, 68 (03) :475-478
[4]   Denosumab for management of severe hypercalcemia in primary hyperparathyroidism [J].
Eremkina, Anna ;
Krupinova, Julia ;
Dobreva, Ekaterina ;
Gorbacheva, Anna ;
Bibik, Ekaterina ;
Samsonova, Margarita ;
Ajnetdinova, Alina ;
Mokrysheva, Natalya .
ENDOCRINE CONNECTIONS, 2020, 9 (10) :1019-1027
[5]   Immobilization-induced hypercalcemia in a patient with renal failure [J].
Gandhi, Anand ;
Mortensen, Mike ;
Sunny, Sonie ;
Techathaveewat, Pawarid ;
Targovnik, Jerome ;
Alsayed, Mahmoud .
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2021, 2021
[6]  
Mesland JB, AM J PHYS MED REHAB, V2022, P61
[7]   Hypercalcemia as a Biomarker of Poor Prognosis in Frail Elderly Patients with COVID-19 [J].
Pamart, D. ;
Otekpo, M. ;
Asfar, M. ;
Duval, G. ;
Gautier, J. ;
Annweiler, Cedric .
JOURNAL OF NUTRITION HEALTH & AGING, 2021, 25 (10) :1140-1144
[8]  
Sadiq N.M., 2022, HYPERCALCEMIA
[9]  
Tan Can Ozan, 2013, Int J Phys Med Rehabil, V1
[10]   Extreme hypercalcaemia caused by immobilisation due to acute spinal cord injury [J].
Tettero, Jesse Marc ;
van Eeghen, Elmer ;
Kooter, Albertus Jozef .
BMJ CASE REPORTS, 2021, 14 (06)